These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 25663666)

  • 1. Loss of EGF-dependent cell proliferation ability on radioresistant cell HepG2-8960-R.
    Saito Y; Abiko R; Kishida A; Kuwahara Y; Yamamoto Y; Yamamoto F; Fukumoto M; Ohkubo Y
    Cell Biochem Funct; 2015 Mar; 33(2):73-9. PubMed ID: 25663666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of cetuximab and rapamycin enhances the therapeutic efficacy in hepatocellular carcinoma.
    Geng J; Li X; Lang X; Qiao C; Hu M; Yang J; Feng J; Lv M
    Technol Cancer Res Treat; 2014 Aug; 13(4):377-85. PubMed ID: 24325131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma from patients with acute liver failure dampens HepG2 cells to epidermal growth factor induced proliferation response.
    Li W; Long J; Takikawa Y; Suzuki K; Lin S
    Hepatogastroenterology; 2014 Oct; 61(135):2021-7. PubMed ID: 25713905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatitis B virus X promotes HepG2 cell cycle progression and growth via downregulation expression of p16 protein].
    Mai L; Yang L; Kuang JY; Zhu JY; Kang YH; Zhang FC; Xie QF; Gao ZL
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):614-8. PubMed ID: 24119743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired resistance to cetuximab is associated with the overexpression of Ras family members and the loss of radiosensitization in head and neck cancer cells.
    Saki M; Toulany M; Rodemann HP
    Radiother Oncol; 2013 Sep; 108(3):473-8. PubMed ID: 23891090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
    Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
    Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of IFN-gamma, TNF-alpha and EGF on the expression of HLA class I antigen and the proliferation of human hepatocellular carcinoma HepG2 cells.
    Wang D; Yang E; Cheng LY
    Anticancer Res; 1997; 17(1A):181-8. PubMed ID: 9066649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse resistance to radiation in KYSE-150R esophageal carcinoma cell after epidermal growth factor receptor signal pathway inhibition by cetuximab.
    Jing Z; Gong L; Xie CY; Zhang L; Su HF; Deng X; Wu SX
    Radiother Oncol; 2009 Dec; 93(3):468-73. PubMed ID: 19744737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor competes with EGF receptor inhibitors to induce cell death in EGFR-overexpressing tumor cells.
    Song JY; Lee SW; Hong JP; Chang SE; Choe H; Choi J
    Cancer Lett; 2009 Oct; 283(2):135-42. PubMed ID: 19380191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGF receptor in human Chang liver and hepatoma HepG2 cells.
    Yang EB; Wang DF; Mack P; Cheng LY
    Biochem Mol Biol Int; 1996 Apr; 38(4):813-20. PubMed ID: 8728111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cimetidine inhibits epidermal growth factor-induced cell signaling.
    Fujikawa T; Shiraha H; Nakanishi Y; Takaoka N; Ueda N; Suzuki M; Shiratori Y
    J Gastroenterol Hepatol; 2007 Mar; 22(3):436-43. PubMed ID: 17295779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically relevant radioresistant cells efficiently repair DNA double-strand breaks induced by X-rays.
    Kuwahara Y; Li L; Baba T; Nakagawa H; Shimura T; Yamamoto Y; Ohkubo Y; Fukumoto M
    Cancer Sci; 2009 Apr; 100(4):747-52. PubMed ID: 19215227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptin sensitizes radiation-induced cell death via classic mitochondrial, caspase and p53-dependent signaling in HepG2 cells.
    Han SX; Zhu Q; Ma JL; Lv Y; Zhao J; Huang C; Jia X; Ou W; Guo HT
    Mol Med Rep; 2011; 4(1):59-63. PubMed ID: 21461564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on inhibitory effect of triterpenoid saponin from Ardisia japonica TSP02 on proliferation and metastasis of human hepatocellular carcinoma cells and its mechanism].
    Zhao CY; Hui LP; He L; Li Q
    Zhongguo Zhong Yao Za Zhi; 2013 Mar; 38(6):861-5. PubMed ID: 23717968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR status and EGFR ligand expression influence the treatment response of head and neck cancer cell lines.
    Jedlinski A; Ansell A; Johansson AC; Roberg K
    J Oral Pathol Med; 2013 Jan; 42(1):26-36. PubMed ID: 22643066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cetuximab enhances the anti-proliferative effect of trastuzumab in ERBB2 over-expressing breast cancer cells--preliminary study.
    Uberall I; Krízová K; Steigerová J
    Klin Onkol; 2011; 24(5):356-60. PubMed ID: 22070017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor-induced cell death and radiosensitization in epidermal growth factor receptor-overexpressing cancer cell lines.
    Kim K; Wu HG; Jeon SR
    Anticancer Res; 2015 Jan; 35(1):245-53. PubMed ID: 25550557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor.
    Wu YM; Liu CH; Hu RH; Huang MJ; Lee JJ; Chen CH; Huang J; Lai HS; Lee PH; Hsu WM; Huang HC; Huang MC
    Cancer Res; 2011 Dec; 71(23):7270-9. PubMed ID: 21990321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorafenib inhibition of hepatic stellate cell proliferation in tumor microenvironment of hepatocellular carcinoma: a study of the sorafenib mechanisms.
    Geng ZM; Jha RK; Li B; Chen C; Li WZ; Zheng JB; Wang L; Huanchen S
    Cell Biochem Biophys; 2014 Jul; 69(3):717-24. PubMed ID: 24633454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of p21CIP1 expression mediated by ERK-dependent and -independent pathways contributes to hepatocyte growth factor-induced inhibition of HepG2 hepatoma cell proliferation.
    Shirako E; Hirayama N; Tsukada Y; Tanaka T; Kitamura N
    J Cell Biochem; 2008 May; 104(1):176-88. PubMed ID: 18004740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.